About Aqua Heart
Aqua Heart is a company based in Santa Ana (United States) founded in 2018. It operates as a B2B, and Enterprise Contracts. Aqua Heart has raised $2.58 million across 1 funding round. Aqua Heart offers products and services including Single-shot Pulmonary Vein Isolation Therapy and Heart Ablation System. Aqua Heart operates in a competitive market with competitors including Imricor, Endosense, Ablation Frontiers, DC Medical and AblaCor, among others.
- Headquarter Santa Ana, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Aqua Heart Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.58 M (USD)
in 1 rounds
-
Latest Funding Round
$2.58 M (USD), Seed
Dec 15, 2025
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aqua Heart
Aqua Heart offers a comprehensive portfolio of products and services, including Single-shot Pulmonary Vein Isolation Therapy and Heart Ablation System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides high-energy ablation for fast, safe atrial fibrillation treatment.
Enables simple, anatomical-based procedures for broader patient access.
Funding Insights of Aqua Heart
Aqua Heart has successfully raised a total of $2.58M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.58 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.6M
-
First Round
First Round
(15 Dec 2025)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Seed - Aqua Heart | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Aqua Heart
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aqua Heart
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aqua Heart Comparisons
Competitors of Aqua Heart
Aqua Heart operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imricor, Endosense, Ablation Frontiers, DC Medical and AblaCor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
MRI-compatible electrophysiology tools for cardiac arrhythmia treatment are developed.
|
|
| domain | founded_year | HQ Location |
Catheter ablation technology for treating cardiac arrhythmias is developed.
|
|
| domain | founded_year | HQ Location |
Cardiac ablation devices are developed for arrhythmia treatment.
|
|
| domain | founded_year | HQ Location |
Develops innovative biomimetic mesh and premature birth diagnostic kits for medical applications.
|
|
| domain | founded_year | HQ Location |
Develops ablation catheter technology for treating atrial fibrillation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Aqua Heart
When was Aqua Heart founded?
Aqua Heart was founded in 2018 and raised its 1st funding round 7 years after it was founded.
Where is Aqua Heart located?
Aqua Heart is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.
Is Aqua Heart a funded company?
Aqua Heart is a funded company, having raised a total of $2.58M across 1 funding round to date. The company's 1st funding round was a Seed of $2.58M, raised on Dec 15, 2025.
What does Aqua Heart do?
AquaHeart is a MedTech startup that creates high-energy, short-duration Pulmonary Vein Isolation devices to treat atrial fibrillation safely and efficiently. It focuses on democratizing heart ablation by simplifying procedures and reducing the need for specialized facilities. Based in Santa Ana, USA, the company collaborates with experts to address unmet needs in cardiovascular care, aiming to reach more patients globally through innovative solutions and regulatory approvals.
Who are the top competitors of Aqua Heart?
Aqua Heart's top competitors include Imricor, Endosense and Ablation Frontiers.
What products or services does Aqua Heart offer?
Aqua Heart offers Single-shot Pulmonary Vein Isolation Therapy and Heart Ablation System.